Skip to main content
HERAMED LIMITED logo

HERAMED LIMITED — Investor Relations & Filings

Ticker · HMD ISIN · AU0000028367 LEI · 875500WOB41XBFTTJ477 ASX Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2022-02-20 Capital/Financing Update
Country AU Australia
Listing ASX HMD

About HERAMED LIMITED

https://hera-med.com/

HeraMED Limited is a medical technology company specializing in the development and commercialization of digital health solutions for maternity care. The company focuses on providing remote monitoring tools that bridge the gap between expectant mothers and healthcare providers. Its flagship product, HeraBEAT, is a medical-grade, smartphone-based fetal heart rate monitor designed for home use, allowing for accurate and reliable monitoring of fetal well-being. This hardware is integrated into the HeraCARE platform, a comprehensive digital maternity care solution that enables remote data management, personalized care plans, and seamless communication between patients and clinicians. By leveraging cloud-based technology and advanced sensors, the company aims to enhance prenatal care, improve clinical outcomes, and offer peace of mind through continuous, data-driven insights throughout the pregnancy journey.

Recent filings

Filing Released Lang Actions
Cleansing Notice 1 page 107.5KB
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 21 February 2022 regarding the exercise of options and issuance of shares by HeraMED Limited. It references compliance with section 708A(5)(e) of the Corporations Act and provides a cleansing notice related to the issuance of shares without disclosure under Part 6D.2 of the Act. The document does not contain financial statements or detailed financial data, nor does it present a report or detailed analysis. It is a regulatory announcement about a capital transaction (exercise of options and share issuance) and compliance with disclosure requirements. Given the content and length (1947 characters), this fits best under Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes.
2022-02-20 English
Quarterly Activities & Cashflow Report 9 pages 317.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 31 January 2022 providing a quarterly update on commercialisation progress, clinical trials, and financing activities for the quarter ending 31 December 2021 (Q4 FY21). It includes operational highlights, commercial agreements, pilot program updates, clinical trial status, government tender information, and financial overview including cash balance and expenses. The document also mentions a convertible note placement and option exercises as financing activities. The content is typical of a quarterly business update rather than a full interim report with detailed financial statements or a formal earnings release with key financial highlights only. It is not a full Annual Report or Audit Report. The document is about ongoing business progress and capital raising updates, which fits best under Capital/Financing Update (CAP). The length (15,000 characters) and detailed operational and financial information support this classification with high confidence.
2022-01-30 English
Application for quotation of securities - HMD 7 pages 30.7KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, prices, and classifications of securities. This is a formal announcement related to changes in the company's capital structure, specifically the issuance and quotation of new shares resulting from option exercises. It does not contain financial statements, management discussion, or audit information. Therefore, it fits the category of a Share Issue/Capital Change announcement rather than a full financial report or other types of filings.
2022-01-27 English
Cleansing Notice 1 page 123.5KB
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 28 January 2022 regarding the exercise of options and issuance of shares by HeraMED Limited. It references compliance with section 708A(5)(e) of the Corporations Act and provides details about the shares issued without disclosure under Part 6D.2 of the Act. The document is brief (2104 characters) and does not contain any financial statements, detailed financial data, or management discussion. It is a regulatory announcement about a capital transaction (exercise of options and share issuance) rather than a full financial report or detailed capital raising document. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2022-01-27 English
JHC agrees to full commercial rollout of HeraCARE 3 pages 165.4KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 21 January 2022 regarding a commercial agreement between HeraMED Limited and Joondalup Health Campus for the rollout of the HeraCARE solution. It details the terms of the agreement, contract value, and background on the clinical trials and pilot phases. The document is a corporate announcement about a commercial contract and does not contain financial statements, audit information, management changes, or regulatory filings. It is not a report, transcript, or presentation but a business update announcement. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous corporate announcements that do not fit other specific categories.
2022-01-20 English
Reinstatement to Official Quotation 1 page 89.8KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from ASX regarding the reinstatement to quotation of HeraMED Limited's securities following a commercial license agreement announcement. It is a short notice about trading suspension being lifted, not a detailed financial report or regulatory filing. It does not contain financial data, management discussion, or detailed report content. It is an official regulatory announcement related to market trading status, fitting best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-01-20 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.